The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price ...

Its quarterly dividend payment ... just identified what they believe are the 10 best stocks for investors to buy now… and Royalty Pharma Plc wasn’t one of them. The 10 stocks that made ...

Fund manager Jonathan Boyar and his team highlighted several stocks that could get a boost thanks to activist shareholders.

The firm has roots tracing back to 1849, and it has a reliable and sustainable dividend. That said, it is also one of the riskier pharma stocks right now. Crown Castle may not be the best-known S ...

Owning stocks with big dividends might finally start paying off. Dividend-paying stalwarts such as JPMorgan Chase and Merck are primed to fare better in the coming year, some investors said.

Investors can look forward to continued growth of Royalty Pharma's bottom line and dividend payout ... Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions ...

Royalty Pharma has royalty stakes in dozens of ... AbbVie is one of the more attractive dividend-paying stocks in the pharmaceutical industry, with a 3.6% yield at recent prices.

Royalty Pharma (NASDAQ: RPRX), W.P. Carey (NYSE ... At their beaten-down prices, these stocks offer juicy dividend yields, and there's a good chance they can maintain or raise their payouts ...